Studies of Human Inference Using On-line Testing

May 14, 2026 updated by: Tahra Eissa, University of Colorado, Boulder
The investigators will record behavioral responses from human participants on crowdsourcing platform Prolific to identify the decision strategies humans apply short-term, long-term, and multi timescale (across both timescales) inference tasks. Participants will perform a flexible decision-making task (described in Research Strategy Aim 1) in which subjects must determine which of two locations a series of evidence (package drops) came from. Subjects must 1) report the current location, 2) predict the next location. The investigators will record these responses, the number (and sequence) of evidence, and the response time (time from the end of trial until the response) for each trial. Subjects will perform all blocks (parameters and number of blocks to be determined by inference model development and testing prior to task development) so that we can compare responses at each timescale. Since participants participate voluntarily for small sums of money (around $12/ hour based on duration of task) and the investigators' previous studies have collected over 200 subjects in a matter of days, they will aim to record behavioral data from 1000 subjects. This number allows them to address the broad range of subject variability expected using Bayesian statistical methods such as Bayes factors.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Colorado
      • Boulder, Colorado, United States, 80309
        • Recruiting
        • University of Colorado Boulder
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adult Prolific participants who have a 95% approval rating and achieve a minimum score of 80% on our pre-test,
  • Speak fluent English
  • Are in the US.

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Environmental Feature Experiment
Subjects will be shown two locations and a series of package drops that switch between the two locations with an unknown frequency. Subjects must identify which location is current in use and which location will be selected next. Subjects know that the frequency of the location changes is different in each block but not its exact value

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Binary Behavioral Decision Responses
Time Frame: Through task completion on each task trial, approximately 1-5x/ minute for approximate 30 minutes
Subject- provided choices (responses on the computer) between two presented options
Through task completion on each task trial, approximately 1-5x/ minute for approximate 30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tahra Eissa, University of Colorado, Denver

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

June 30, 2028

Study Registration Dates

First Submitted

April 19, 2023

First Submitted That Met QC Criteria

April 28, 2023

First Posted (Actual)

May 8, 2023

Study Record Updates

Last Update Posted (Actual)

May 18, 2026

Last Update Submitted That Met QC Criteria

May 14, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The task structure will be preregistered to Open Science Framework (OSF) prior to data acquisition. De-identified data will be posted to OSF following publication.

IPD Sharing Time Frame

The data will be made available following publication.

IPD Sharing Access Criteria

IPD will be available on OSF to all who are interested.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Behavior

Clinical Trials on psychophysics

Subscribe